KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Capital Employed (2016 - 2025)

Pacira BioSciences (PCRX) has 15 years of Return on Capital Employed data on record, last reported at 0.02% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 8.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.02%, up 8.0%, while the annual FY2025 figure was 0.01%, 7.0% up from the prior year.
  • Return on Capital Employed reached 0.02% in Q4 2025 per PCRX's latest filing, down from 0.03% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.09% in Q3 2021 and bottomed at 0.08% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.04% recorded in 2022.
  • The widest YoY moves for Return on Capital Employed: up 8bps in 2025, down -14bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.08% in 2021, then tumbled by -49bps to 0.04% in 2022, then soared by 56bps to 0.06% in 2023, then tumbled by -199bps to 0.06% in 2024, then skyrocketed by 128bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.02% in Q4 2025, 0.03% in Q3 2025, and 0.08% in Q2 2025.